MedTrace Logo

Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

NCT04551144 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2024-01-08

No results posted yet for this study

Summary

The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.

Conditions

Interventions

DRUG

testosterone cypionate

intramuscular injection every 2 weeks. Dose will be titrated based on blood levels

DRUG

Estradiol Valerate

intramuscular injection every week. Dose will be titrated based on blood levels

Sponsors & Collaborators

  • St. Louis University

    lead OTHER

Principal Investigators

  • Sandeep Dhindsa, MD · St. Louis University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2023-01-18
Completion
2023-01-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04551144 on ClinicalTrials.gov